![]() |
Ovarian Neoplasms |
Free Subscription
2 Br J Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Cost-effectiveness of CA125- and age-informed risk-based triage for ovarian
cancer detection in primary care.
Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03166.
PubMed
Abstract available
CA125 and age-based models for ovarian cancer detection in primary care: a
population-based external validation study.
Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03165.
PubMed
Abstract available
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell
adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2
trial.
Clin Cancer Res. 2025 Jul 24. doi: 10.1158/1078-0432.CCR-25-0201.
PubMed
Abstract available
Age-specific incidence and five-year relative survival of endometrial cancer
histotypes by race and ethnicity among US women, 2000 to 2019.
Gynecol Oncol. 2025;200:137-144.
PubMed
Abstract available
Ovarian mixed low- and high-grade serous carcinoma as a synchronous or
metachronous phenomenon: A clinicopathologic study of 39 cases.
Gynecol Oncol. 2025;200:130-136.
PubMed
Abstract available
Polycystic ovary syndrome and the risk of ovarian tumours.
Gynecol Oncol. 2025;200:1-7.
PubMed
Abstract available
Chemotherapy as a double-edged sword: Modulation of tumor-associated cytokine and
chemokine responses in ovarian cancer.
Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70132.
PubMed
Abstract available
Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer.
PLoS Genet. 2025;21:e1011660.
PubMed
Abstract available
Thank you for your interest in scientific medicine.